ストックスクリーナーアプリを入手
10.05
2.60%
0.255
アフターアワーズ：
10.03
-0.02
-0.20%
前日終値:
$9.795
開ける：
$9.95
24時間の取引高:
82,480
Relative Volume:
1.98
時価総額：
$31.95M
収益：
-
当期純損益:
$-68.80M
株価収益率:
-8.5897
EPS:
-1.17
ネットキャッシュフロー:
$-59.06M
1週間 パフォーマンス:
+1.31%
1か月 パフォーマンス:
+13.56%
6か月 パフォーマンス:
+2,470%
1年 パフォーマンス:
+1,224%
1日の値動き範囲:
$9.66
$10.48
1週間の範囲:
$9.66
$10.71
52週間の値動き範囲:
$0.257
$10.71
Passage Bio Inc Stock (PASG) Company Profile
名前
Passage Bio Inc
セクター
電話
(267) 866-0312
住所
ONE COMMERCE SQUARE, PHILADELPHIA, PA
PASG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
10.05 | 31.14M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-29 | 再開されました | Wedbush | Outperform |
| 2024-09-03 | 開始されました | Rodman & Renshaw | Buy |
| 2022-03-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-01-19 | ダウングレード | Goldman | Buy → Neutral |
| 2021-07-01 | 開始されました | Raymond James | Outperform |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-03-04 | アップグレード | Goldman | Neutral → Buy |
| 2021-02-04 | 開始されました | Guggenheim | Buy |
| 2021-01-25 | 開始されました | Wedbush | Outperform |
| 2021-01-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-12-11 | 開始されました | Citigroup | Neutral |
| 2020-08-14 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-06-25 | ダウングレード | Goldman | Buy → Neutral |
| 2020-03-25 | 開始されました | Chardan Capital Markets | Buy |
| 2020-03-24 | 開始されました | Cowen | Outperform |
| 2020-03-24 | 開始されました | Goldman | Buy |
| 2020-03-24 | 開始されました | JP Morgan | Overweight |
すべてを表示
Passage Bio Inc (PASG) 最新ニュース
Financial Comparison: Passage Bio (NASDAQ:PASG) versus PepGen (NASDAQ:PEPG) - Defense World
Passage Bio (PASG) Price Target Increased by 21.85% to 40.39 - Nasdaq
What drives Passage Bio Inc stock priceGrowth Stock Opportunities & Affordable Investment Portfolio - earlytimes.in
How Passage Bio Inc. stock compares to industry benchmarksPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Passage Bio Inc Stock Analysis and ForecastInstitutional Buying Trends & Capitalize On Fast Trends - earlytimes.in
Can Divgi TorqTransfer Systems Limited Compete Globally or Is It a Local Player OnlyDividend Reinvestment Plans & Use Smart Algorithms to Pick Better Stocks - earlytimes.in
Is Passage Bio Inc. stock a safe haven assetMarket Growth Report & Pattern Based Trade Signal System - Newser
Why Passage Bio Inc. stock is a must watch in 2025Market Rally & Free Community Supported Trade Ideas - Newser
Will Passage Bio Inc. stock sustain high P E ratiosEarnings Summary Report & Safe Entry Momentum Stock Tips - moha.gov.vn
Passage Bio to Present at Two Major Investor Conferences - MSN
Gains Recap: Why Passage Bio Inc. stock is seen as undervalued2025 Momentum Check & Free High Accuracy Swing Entry Alerts - moha.gov.vn
Why Passage Bio Inc. stock is rated strong buyJuly 2025 Weekly Recap & Long Hold Capital Preservation Plans - moha.gov.vn
How currency fluctuations impact Passage Bio Inc. stockMarket Risk Analysis & Verified Stock Trade Ideas - moha.gov.vn
Risk Off: Will Passage Bio Inc. stock sustain high P E ratiosQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - moha.gov.vn
Brokerages Set Passage Bio, Inc. (NASDAQ:PASG) Target Price at $42.67 - Defense World
Ocugen CEO to Spotlight Gene Therapy Breakthroughs at High-Profile Growth Conference - MyChesCo
Passage Bio (PASG) Price Target Decreased by 45.15% to 33.15 - MSN
Lucid Capital Markets initiates Passage Bio stock with Buy rating By Investing.com - Investing.com Canada
Lucid Capital Markets initiates Passage Bio stock with Buy rating - Investing.com India
Passage Bio, Inc. (PASG) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
How Passage Bio Inc. stock compares to market leadersInsider Selling & AI Powered Market Trend Analysis - newser.com
Is Passage Bio Inc. stock bottoming out2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Passage Bio Pushes Toward Key 2026 Milestones as Gene Therapy Program Accelerates - MSN
How Passage Bio Inc. stock reacts to Fed rate cuts2025 Momentum Check & Low Risk High Win Rate Picks - newser.com
Applying chart zones and confluence areas to Passage Bio Inc.2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
What momentum shifts mean for Passage Bio Inc.July 2025 Technicals & Safe Entry Trade Reports - newser.com
Chardan Capital Expects Reduced Earnings for Passage Bio - Defense World
Passage Bio Inc. stock trendline breakdownWeekly Trade Recap & Weekly Return Optimization Alerts - newser.com
Ranking Passage Bio Inc. among high performing stocks via toolsQuarterly Earnings Summary & Long-Term Safe Investment Ideas - newser.com
Passage Bio, Inc.Common Stock (NQ: PASG - FinancialContent
Using economic indicators to assess Passage Bio Inc. potentialQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
How Passage Bio Inc. stock reacts to global recession fearsEarnings Miss & Real-Time Volume Triggers - newser.com
Chardan Capital Raises Passage Bio (NASDAQ:PASG) Price Target to $21.00 - Defense World
Passage Bio (NASDAQ:PASG) Price Target Raised to $21.00 - Defense World
Can Passage Bio Inc. stock attract ESG capital inflowsJuly 2025 Outlook & Precise Swing Trade Entry Alerts - Fundação Cultural do Pará
Is Passage Bio Inc. stock a contrarian buyJuly 2025 Final Week & Weekly Stock Breakout Alerts - Fundação Cultural do Pará
What is Wedbush’s Forecast for Passage Bio FY2025 Earnings? - Defense World
Passage Bio Inc (PASG) 財務データ
収益
当期純利益
現金流量
EPS
0.36%
1.05%
大文字化:
|
ボリューム (24 時間):